ImmunityBio, Inc.
IBRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001326110
In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 3 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in ImmunityBio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- −6 vs. Q2 2022
- Shares held
- 39.5M
- +6.38M (+19.3%) vs. Q2 2022
- Total value
- $196.3M
- +$73.3M (+59.6%) vs. Q2 2022
- New holders
- 17
- 49 more added
- Sold out
- 23
- 27 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 405 | $1.76B |
| Q1 2026 | 386 | $1.36B |
| Q4 2025 | 278 | $338.3M |
| Q3 2025 | 264 | $352.1M |
| Q2 2025 | 242 | $327.9M |
| Q1 2025 | 211 | $239.4M |
| Q4 2024 | 202 | $211.8M |
| Q3 2024 | 182 | $255.6M |
| Q2 2024 | 194 | $391.1M |
| Q1 2024 | 166 | $356.9M |
| Q4 2023 | 148 | $288.9M |
| Q3 2023 | 132 | $84.1M |
| Q2 2023 | 118 | $108.7M |
| Q1 2023 | 147 | $84.1M |
| Q4 2022 | 140 | $256.0M |
| Q3 2022 | 126 | $196.3M |
| Q2 2022 | 132 | $123.1M |
| Q1 2022 | 149 | $199.8M |
| Q4 2021 | 141 | $209.7M |
| Q3 2021 | 121 | $310.9M |
| Q2 2021 | 118 | $390.1M |
| Q1 2021 | 116 | $378.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ImmunityBio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 269,983 | $1.34M | 0.00% | −3,855−1.4% | Reduced |
| Winning Points Advisors, LLC | 251,556 | $1.39M | 1.69% | +14,600+6.2% | Added |
| Swiss National Bank | 281,100 | $1.40M | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 293,350 | $1.46M | 0.00% | +245,781+516.7% | Added |
| Oracle Investment Management Inc | 315,322 | $1.57M | 0.90% | +315,322 | New |
| HarbourVest Partners LLC | 335,709 | $1.67M | 0.55% | 00.0% | Unchanged |
| Citigroup Inc | 373,644 | $1.86M | 0.00% | +358,916+2,437.0% | Added |
| Group One Trading, L.P. | 380,688 | $1.89M | 0.06% | +31,436+9.0% | Added |
| Millennium Management LLC | 399,271 | $1.98M | 0.00% | −780,514−66.2% | Reduced |
| Rafferty Asset Management, LLC | 404,440 | $2.01M | 0.02% | +120,118+42.2% | Added |
| Bank of New York Mellon Corp | 441,498 | $2.19M | 0.00% | +83,140+23.2% | Added |
| Citadel Advisors LLC | 548,154 | $2.72M | 0.00% | −229,827−29.5% | Reduced |
| Goldman Sachs Group Inc | 565,843 | $2.81M | 0.00% | −4,997−0.9% | Reduced |
| Susquehanna International Group, LLP | 630,766 | $3.13M | 0.01% | +56,047+9.8% | Added |
| Pictet Asset Management SA | 638,177 | $3.17M | 0.00% | +197,199+44.7% | Added |
| Morgan Stanley | 641,813 | $3.19M | 0.00% | −336,830−34.4% | Reduced |
| D. E. Shaw & Co., Inc. | 678,504 | $3.37M | 0.01% | +267,827+65.2% | Added |
| Allen Holding Inc | 687,571 | $3.42M | 0.54% | 00.0% | Unchanged |
| Credit Suisse AG | 698,052 | $3.47M | 0.00% | +9,578+1.4% | Added |
| Charles Schwab Investment Management Inc | 712,218 | $3.54M | 0.00% | +237,948+50.2% | Added |
| Northern Trust Corp | 810,889 | $4.03M | 0.00% | +56,015+7.4% | Added |
| JPMorgan Chase & Co | 1,563,263 | $7.77M | 0.00% | +401,369+34.5% | Added |
| Geode Capital Management, LLC | 1,921,589 | $9.55M | 0.00% | +348,755+22.2% | Added |
| BlackRock Inc. | 6,217,199 | $30.9M | 0.00% | +309,550+5.2% | Added |
| State Street Corp | 6,649,331 | $33.0M | 0.00% | +4,780,807+255.9% | Added |
| Vanguard Group Inc | 8,079,541 | $40.2M | 0.00% | +557,164+7.4% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −401,681−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −135,655−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −135,300−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −95,140−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −84,884−100.0% | Sold out |
| Stonehage Fleming Financial Services Holdings Ltd | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −54,717−100.0% | Sold out |
| GAM Holding AG | 0 | $0 | 0.00% | −54,178−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −47,400−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −40,417−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −31,709−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −29,032−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −26,500−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −21,076−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −19,223−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −15,200−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −14,782−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −11,741−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −9,734−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,920−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −30−100.0% | Sold out |